On June 13, FP2020 and AVAC held a webinar, A Roadmap for Results: Understanding the ECHO Study Results, with the ECHO team following the results announcement. The webinar explained the trial, provided topline results, outlined next steps, and offered key advocacy messages to help all stakeholders understand the findings.
Watch here.
In this episode of Px Pulse, AVAC spoke with two leaders from the ECHO trial team, Dr. Jared Baeten and Dr. Helen Rees, to understand what the trial can and cannot tell us. And you’ll hear leading women’s advocates from several countries where the ECHO trial took place share their demands. Carry what you learn forward as the ECHO trial raises the volume on an urgent conversation—how to empower African women around their sexual and reproductive health.
Civil society led by and for women in Africa is working with allies around the world to prepare for the ECHO results and advance a broader agenda of sexual health and rights that centers women and affirms the right to full information and informed choice, as well as integration of HIV and sexual and reproductive health programs. Reports from civil society forum meetings in 2018, as well as key resources, are available here.
The Evidence for Contraceptive Options and HIV Outcomes (ECHO) Study is an open-label, randomized, clinical trial comparing three highly effective, reversible methods of contraception — the progestogen-only injectable depot-medroxyprogesterone acetate (DMPA), a levonorgestrel implant, and the non-hormonal copper intrauterine device — to evaluate whether there is any difference in the risk of acquiring HIV infection among users of these methods.
Results, expected in mid-2019, will help guide the implementation of safe, effective policies and services that will enable women at high risk of HIV to make fully informed choices about contraception and HIV prevention.
The webinar featured:
Beth Schlachter, Executive Director, FP2020
Dr. Jared Baeten, Vice Chair, Department of Global Health, University of Washington, ECHO Consortium
Dr. Nelly Mugo, Research Associate Professor, Global Health, University of Washington, ECHO Management Committee
Tamar Abrams, Communications Director, FP2020
You may view the webinar here.
A slide deck overview of what’s happening in HIV vaccine research now.
Scientists are studying these strategies to develop an effective vaccines and deliver it into the body in a way that maximizes the immune response.
Numerous studies, both early and late phase, are investigating the efficacy of neutralizing antibodies. This infographic shows the ongoing studies and the differing locations they target on the virus.
A look at the percentage of total funds invested in different aspects of vaccine research.
A look at the number of participants in vaccines trials in 2019 according to trial phase.
This episode of Px Pulse features unmissable conversations about some of the challenges associated with today’s HIV prevention options, and analysis about what should be in the research pipeline from 2021 to 2027.